Mesoblast (MEOBF) Net Margin Growth (1y) (2015 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) Net Margin Growth (1y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 603.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.25 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 13,865.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 6,876.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -67,094.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -2.38 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 314,889.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -3,345.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -22,379.00 |
| Mar 31, 2023 | 10,002.00 |
| Dec 31, 2022 | -41,368.00 |
| Sep 30, 2022 | -49,328.00 |
| Jun 30, 2022 | 5,920.00 |
| Mar 31, 2022 | 32,532.00 |
| Dec 31, 2021 | 41,271.00 |
| Sep 30, 2021 | 125,069.00 |
| Mar 31, 2021 | -124,048.00 |
| Dec 31, 2020 | -31,357.00 |
| Sep 30, 2020 | -184,860.00 |
| Mar 31, 2020 | 185,509.00 |
| Dec 31, 2019 | 48,284.00 |
| Sep 30, 2019 | 13,538.00 |
| Jun 30, 2019 | -15,119.00 |
| Mar 31, 2019 | -2,378.00 |
| Dec 31, 2018 | -141,801.00 |
| Sep 30, 2018 | 92,427.00 |
| Jun 30, 2018 | 357,694.00 |
| Mar 31, 2018 | -20,295.00 |